Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2010
08/12/2010US20100202963 Therapies for hematologic malignancies
08/12/2010US20100202962 Cripto blocking antibodies and uses thereof
08/12/2010US20100202961 Immunological reagents for therapeutic use, in radioimmunotherapy (RAIT), and diagnostic use, in radioimmunodetection (RAID) and magnetic resonance imaging; conjugated drug as antiinflammatory, or anticarcinogenic agents; drug targets; tissue-targeted therapy
08/12/2010DE102009007853A1 Mit Alkylphosphocholinen behandelte Intraokularlinsen zur pharmakologischen Nachstarprophylaxe Treated with alkylphosphocholines intraocular lenses for the pharmacological Nachstarprophylaxe
08/12/2010CA2761389A1 Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens
08/12/2010CA2751987A1 Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs
08/12/2010CA2751695A1 Aminopyrazine derivatives and medicines
08/12/2010CA2751571A1 Sam-6 variants, target and methods of use
08/12/2010CA2751539A1 Derivatives of 6-(6-nh-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
08/12/2010CA2751525A1 Derivatives of 6-(6-o-cycloalkyl or 6-nh-cycloalkyl-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
08/12/2010CA2751495A1 Pharmaceutical compositions comprising a pyridyl cyanoguanidine and cyclodextrin and/or derivatives thereof
08/12/2010CA2751481A1 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
08/12/2010CA2751474A1 Derivatives of 6-(6-substituted-triazolopyridazine-sulfanyl) 5-fluoro-benzothiazoles and 5-fluoro-benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as metinhibitors
08/12/2010CA2751458A1 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
08/12/2010CA2751263A1 Novel saponin compounds, methods of preparation thereof, use thereof and pharmaceutical compositions
08/12/2010CA2750875A1 Derivatives of 6-(6-o-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
08/12/2010CA2750844A1 Triptolide c-ring derivatives as anticancer agents and immune modulators
08/12/2010CA2750038A1 Anti-trop-2 monoclonal antibodies and uses thereof in the treatment and diagnosis of tumors
08/12/2010CA2749209A1 Indole derivatives as anticancer agents
08/12/2010CA2748943A1 Pyrrolopyrimidinyl axl kinase inhibitors
08/12/2010CA2741052A1 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
08/11/2010EP2216409A1 Albumin fusion proteins
08/11/2010EP2216404A1 Method of producing an antibody using a cell in which the function of fucose transporter is inhibited
08/11/2010EP2216344A1 Diagnosis and treatment of cancer using anti-gpr49 antibody
08/11/2010EP2216342A1 Anti-CD19 antibodies
08/11/2010EP2216047A1 Regulator for signaling of toll-like receptor, which comprises cathepsin inhibitor as active ingredient
08/11/2010EP2216046A2 Anti-glypican 3 antibody
08/11/2010EP2216041A1 Method for induction of cytotoxic t-cell, cytotoxic t-cell inducer, and pharmaceutical composition and vaccine each comprising the inducer
08/11/2010EP2216029A2 Oligonucleotides for treatment of prostate and other cancers
08/11/2010EP2216022A1 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors
08/11/2010EP2215121A1 Anti-mesothelin antibodies and uses therefor
08/11/2010EP2215119A1 Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same
08/11/2010EP2215094A1 N-containing heterocyclic compounds
08/11/2010EP2215091A2 Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors
08/11/2010EP2215090A1 Purine derivatives useful as pi3 kinase inhibitors
08/11/2010EP2215089A1 [1h- pyrazolo [3, 4-b]pyridine-4-yl]-phenyle or -pyridin-2-yle derivatives as protein kinase c-theta
08/11/2010EP2215085A2 Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders
08/11/2010EP2215079A1 Inhibitors of c-fms kinase
08/11/2010EP2215064A1 Compounds for inhibiting ksp kinesin activity
08/11/2010EP2214697A2 Nell-1 compositions
08/11/2010EP2214664A2 Brca1-based breast or ovarian cancer prevention agents and methods of use
08/11/2010EP2214662A1 Methods of using (+)-1,4-dihydro-7-ý(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl¨-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapy
08/11/2010EP2214659A1 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders
08/11/2010EP2214485A1 Methods for treatment of cancer
08/11/2010EP1836201B1 Pyrrolidine inhibitors of iap
08/11/2010EP1827492B1 Antibodies directed to gpnmb and uses thereof
08/11/2010EP1796647B1 Stable pegylated interferon formulation
08/11/2010EP1716178B1 Less immunogenic binding molecules
08/11/2010EP1713461B1 Compounds having antitumor activity
08/11/2010EP1515750B1 Combinations comprising epothilones and pharmaceutical uses thereof
08/11/2010EP1483294B1 Internalizing anti-cd74 antibodies and methods of use
08/11/2010EP1150676B1 Acyl derivatives of 4-demethylpenclomedine, use thereof and preparation thereof
08/11/2010CN201542984U Antineoplastic pill
08/11/2010CN1969930B Method for preparing rhodiola root extract transformed by microbe
08/11/2010CN1952160B Recombinant of intelligent adenovirus vector and khp53 gene and application thereof
08/11/2010CN1946727B (Poly) aminoacetamide derivatives of epipodophyllotoxin, their process of preparation and their applications in therapeutics as anticancer agents
08/11/2010CN1840162B Compound total extract of compound cape jasmine, ginger and fermented soybean, its preparation and use
08/11/2010CN1772189B Auxiliary treating medicine for lung cancer in late stage
08/11/2010CN1712399B Production and use for taxol and muramic acyl dipeptide conjugate substance of immune reinforcer
08/11/2010CN1649551B Drug-delivery endovascular stent and method for treating restenosis
08/11/2010CN101803492A Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
08/11/2010CN101802197A Single-chain FC (ScFc) regions, binding polypeptides comprising same, and methods related thereto
08/11/2010CN101802196A RNAi mediated knockdown of NuMA for cancer therapy
08/11/2010CN101802013A Humanized anti-CD79b antibodies and immunoconjugates and methods of use
08/11/2010CN101802012A Anti-CD79b antibodies and immunoconjugates and methods of use
08/11/2010CN101802008A Human C-FMS antigen binding proteins
08/11/2010CN101801975A Pyrazolo-pyrazines derivatives used as g protein inhibitors
08/11/2010CN101801973A Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors
08/11/2010CN101801971A Deazapurines useful as inhibitors of janus kinases
08/11/2010CN101801969A Indolyl pyrrolidines for the treatment of cancer
08/11/2010CN101801966A Bicyclic heteroaryl compounds and their use as kinase inhibitors
08/11/2010CN101801965A Indole compounds as an inhibitor of cellular necrosis
08/11/2010CN101801963A Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
08/11/2010CN101801962A Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
08/11/2010CN101801961A Pyrrolidinone, pyrrolidine-2, 5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
08/11/2010CN101801959A Aminopyrimidines useful as kinase inhibitors
08/11/2010CN101801955A Pyrimidyl cyclopentanes as akt protein kinase inhibitors
08/11/2010CN101801950A Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
08/11/2010CN101801937A Quinazolinone compounds and methods of use thereof
08/11/2010CN101801931A Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
08/11/2010CN101801907A Compounds isolated from antrodia cinnamomea and use thereof
08/11/2010CN101801462A Treatments and diagnostics for cancer, inflammatory disorders and autoimmune disorders
08/11/2010CN101801419A MiR-34 regulated genes and pathways as targets for therapeutic intervention
08/11/2010CN101801390A Medicinal agent for disease associated with epstein-barr virus, and method for screening of the medicinal agent
08/11/2010CN101801383A Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
08/11/2010CN101801379A CSF-1R inhibitors for treatment of cancer and bone diseases
08/11/2010CN101801376A Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors
08/11/2010CN101799476A Reagent box for sieving autoantibody for tsh receptor
08/11/2010CN101798600A Application of SERPINE2 gene
08/11/2010CN101798599A Purpose of hsa-miR-150
08/11/2010CN101798355A Method for integrated separation and extraction of tea polysaccharide, theanine, polyphenol and caffeine
08/11/2010CN101798343A Cancer suppressor gene coding protein sequence and fusion expression vector thereof
08/11/2010CN101798336A Anti-tumour compound with tracking function
08/11/2010CN101798333A Tetraterpene compound and derivatives thereof for treating cancer, inflammation and central nervous system diseases
08/11/2010CN101798308A Preparation process and products of oridonin fine particles
08/11/2010CN101798292A Method for preparing novel Bc1-2 protein inhibitor derived from ABT-263
08/11/2010CN101798284A Azepine brazilin compound and synthesis method thereof
08/11/2010CN101797393A Malignant lymphoma radioactive target molecule imaging agent and/or target therapeutic agent
08/11/2010CN101797392A Palladium-103 and io-125 compound sealed seed source, source core and source core preparation method
08/11/2010CN101797390A Application of gene rabl3 antagonist and medicament containing same
1 ... 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 ... 2211